1. Home
  2. XRAY vs CRSP Comparison

XRAY vs CRSP Comparison

Compare XRAY & CRSP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • XRAY
  • CRSP
  • Stock Information
  • Founded
  • XRAY 1899
  • CRSP 2013
  • Country
  • XRAY United States
  • CRSP Switzerland
  • Employees
  • XRAY N/A
  • CRSP N/A
  • Industry
  • XRAY Medical/Dental Instruments
  • CRSP Biotechnology: Biological Products (No Diagnostic Substances)
  • Sector
  • XRAY Health Care
  • CRSP Health Care
  • Exchange
  • XRAY Nasdaq
  • CRSP Nasdaq
  • Market Cap
  • XRAY 4.8B
  • CRSP 4.3B
  • IPO Year
  • XRAY 1987
  • CRSP 2016
  • Fundamental
  • Price
  • XRAY $19.25
  • CRSP $44.11
  • Analyst Decision
  • XRAY Buy
  • CRSP Buy
  • Analyst Count
  • XRAY 11
  • CRSP 18
  • Target Price
  • XRAY $26.50
  • CRSP $76.60
  • AVG Volume (30 Days)
  • XRAY 2.6M
  • CRSP 1.8M
  • Earning Date
  • XRAY 11-07-2024
  • CRSP 11-05-2024
  • Dividend Yield
  • XRAY 3.32%
  • CRSP N/A
  • EPS Growth
  • XRAY N/A
  • CRSP N/A
  • EPS
  • XRAY N/A
  • CRSP N/A
  • Revenue
  • XRAY $3,900,000,000.00
  • CRSP $202,829,000.00
  • Revenue This Year
  • XRAY N/A
  • CRSP N/A
  • Revenue Next Year
  • XRAY N/A
  • CRSP $758.18
  • P/E Ratio
  • XRAY N/A
  • CRSP N/A
  • Revenue Growth
  • XRAY N/A
  • CRSP 19.31
  • 52 Week Low
  • XRAY $17.21
  • CRSP $42.86
  • 52 Week High
  • XRAY $37.60
  • CRSP $91.10
  • Technical
  • Relative Strength Index (RSI)
  • XRAY 42.75
  • CRSP 39.11
  • Support Level
  • XRAY $18.95
  • CRSP $43.40
  • Resistance Level
  • XRAY $20.35
  • CRSP $53.97
  • Average True Range (ATR)
  • XRAY 0.56
  • CRSP 2.37
  • MACD
  • XRAY 0.14
  • CRSP -0.78
  • Stochastic Oscillator
  • XRAY 21.43
  • CRSP 9.53

About XRAY DENTSPLY SIRONA Inc.

Dentsply Sirona is one of the world's largest manufacturers of dental equipment and supplies. It is a result of a merger of equals in 2016 between Dentsply International (manufactured dental consumables and lab products) and Sirona Dental Systems (manufactured technologically-advanced dental equipment). The firm's wide portfolio consists of dental consumables, lab products, CAD/CAM and imaging technology, medical devices, and specialty products in orthodontics, endodontics, and implantation. It distributes two-thirds of its dental consumables, technology and equipment through third-party distributors and the remaining portfolio is either sold to labs and offices through the firm's salesforce or directly to consumers (such as Byte clear aligner).

About CRSP CRISPR Therapeutics AG

Crispr Therapeutics is a gene editing company focused on the development of Crispr/Cas9-based therapeutics. Crispr/Cas9 stands for clustered regularly interspaced short palindromic repeats (Crispr)/Crispr-associated protein 9 (Cas9), which is a revolutionary technology for precisely altering specific sequences of genomic DNA. The company is focused on using this technology to treat genetically defined diseases. Crispr's first approved drug is Casgevy, which was developed in collaboration with Vertex Pharmaceuticals and targets sickle-cell disease and transfusion-dependent beta-thalassemia, which have high unmet medical needs. The company is advancing a variety of gene editing programs in immuno-oncology, cardiovascular, and a stem cell-derived therapy to treat Type 1 diabetes.

Share on Social Networks: